Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cirrhosis II: Pathophysiology01:24

Cirrhosis II: Pathophysiology

Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to structural...
Liver Regeneration01:24

Liver Regeneration

The liver is an important organ in vertebrates that plays an essential role in metabolism. It is also responsible for storing and redistributing nutrients such as carbohydrates, fats, and vitamins in the body. Additionally, the liver releases bile salts which are critical for digesting food and eliminating toxic metabolites from the body.
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are large...
Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
Cirrhosis I: Introduction01:23

Cirrhosis I: Introduction

Cirrhosis is a chronic, irreversible liver disease characterized by the widespread replacement of healthy liver tissue with fibrotic scar tissue and the formation of regenerative nodules.Etiology of cirrhosisCirrhosis results from sustained liver injury that triggers progressive fibrosis and structural remodeling. The underlying causes are diverse, encompassing common and less frequent clinical conditions. Regardless of the origin, all causes lead to chronic inflammation, hepatocyte loss, and...
Hepatic Encephalopathy01:29

Hepatic Encephalopathy

DefinitionHepatic encephalopathy is a reversible neurologic syndrome that results from advanced liver dysfunction or portosystemic shunting. It leads to disturbances in cognition, behavior, and motor function due to the brain’s exposure to gut-derived toxins that the liver fails to detoxify.EtiologyThis condition develops either in the setting of acute fulminant hepatitis or progressively during chronic liver disease, such as cirrhosis and portal hypertension. Portosystemic shunting—including...
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow01:26

Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow

Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug binding...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Development of the Perihilar Cholangiocarcinoma Risk Estimation of Tumor Recurrence After Transplant (PRETREAT) Score.

Annals of surgery·2025
Same author

Differential MYC Phosphorylation Drives the Divergent Cholangiocyte Response to Stress.

Cellular and molecular gastroenterology and hepatology·2025
Same author

Deep learning-based uncertainty quantification for quality assurance in hepatobiliary imaging-based techniques.

Oncotarget·2025
Same author

Deep learning analysis of MRI accurately detects early-stage perihilar cholangiocarcinoma in patients with primary sclerosing cholangitis.

Hepatology (Baltimore, Md.)·2025
Same author

The dynamic landscape of cholestatic liver disease.

Hepatology (Baltimore, Md.)·2025
Same author

Aptamer-directed, nanovesicle-mediated targeting of undruggable molecules in preclinical cholangiocarcinoma models.

Hepatology (Baltimore, Md.)·2025

Related Experiment Video

Updated: Jun 10, 2026

Isolation of Regenerating Hepatocytes after Partial Hepatectomy in Mice
10:04

Isolation of Regenerating Hepatocytes after Partial Hepatectomy in Mice

Published on: December 2, 2022

Hepatocyte death: a clear and present danger.

Harmeet Malhi1, Maria Eugenia Guicciardi, Gregory J Gores

  • 1Division of Gastroenterology and Hepatology, College of Medicine, Mayo Clinic, Rochester, Minnesota 55905, USA.

Physiological Reviews
|July 29, 2010
PubMed
Summary

Hepatocytes are vulnerable to injury due to their metabolic roles and immune interactions. Understanding apoptosis and necrosis pathways offers therapeutic strategies for liver injury.

More Related Videos

A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma
12:24

A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma

Published on: September 30, 2021

Cell Type-specific Gene Expression Profiling in the Mouse Liver
10:06

Cell Type-specific Gene Expression Profiling in the Mouse Liver

Published on: September 17, 2019

Related Experiment Videos

Last Updated: Jun 10, 2026

Isolation of Regenerating Hepatocytes after Partial Hepatectomy in Mice
10:04

Isolation of Regenerating Hepatocytes after Partial Hepatectomy in Mice

Published on: December 2, 2022

A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma
12:24

A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma

Published on: September 30, 2021

Cell Type-specific Gene Expression Profiling in the Mouse Liver
10:06

Cell Type-specific Gene Expression Profiling in the Mouse Liver

Published on: September 17, 2019

Area of Science:

  • Hepatology
  • Cell Biology
  • Toxicology

Background:

  • Hepatocytes are central to xenobiotic metabolism, lipid metabolism, bile acid circulation, and immune responses, making them susceptible to injury.
  • Hepatocyte cell death occurs via apoptosis and necrosis, with unique apoptotic pathways involving death receptors and mitochondria.
  • Specific anti-apoptotic proteins (Bcl-x(L), Mcl-1) and endoplasmic reticulum stress also influence hepatocyte survival and death.

Purpose of the Study:

  • To review the mechanisms of hepatocyte cell death, focusing on apoptosis and necrosis.
  • To discuss the roles of death receptors, mitochondrial pathways, lysosomal disruption, and anti-apoptotic proteins in hepatocyte apoptosis.
  • To explore the contribution of endoplasmic reticulum stress and RIP kinases to hepatocyte injury and cell death.

Main Methods:

  • Review of existing literature on hepatocyte cell death mechanisms.
  • Analysis of signaling pathways involved in apoptosis and necrosis.
  • Discussion of the interplay between metabolic functions and cell death pathways.

Main Results:

  • Hepatocytes are uniquely susceptible to death receptor-mediated apoptosis, involving mitochondrial and lysosomal pathways.
  • Bcl-x(L) and Mcl-1 are key nonredundant anti-apoptotic proteins in hepatocytes.
  • Endoplasmic reticulum stress and RIP kinases are implicated in hepatocyte necrosis and injury.

Conclusions:

  • Hepatocyte injury involves complex apoptosis and necrosis pathways influenced by metabolic and immune factors.
  • Targeting death receptor signaling, mitochondrial pathways, and RIP kinases may offer therapeutic strategies for liver diseases.
  • Further research into these mechanisms is crucial for developing effective treatments for hepatocyte injury.